10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 131,072 | 114,609 | 114,496 | 143,530 | 125,297 |
| Cost of Goods | 30,377 | 27,704 | 25,478 | 27,598 | 24,518 |
| Gross Profit | 100,695 | 86,905 | 89,018 | 115,932 | 100,779 |
| Operating Expenses | 141,068 | 150,726 | 131,231 | 132,360 | 117,176 |
| Operating Income | -39,996 | -63,117 | -41,735 | -15,830 | -15,879 |
| Interest Expense | 114 | 109 | 128 | 217 | 219 |
| Other Income | 75 | -605 | 169 | 54 | -550 |
| Pre-tax Income | -40,035 | -63,831 | -41,694 | -15,993 | -16,648 |
| Income Tax | 1,879 | 627 | 719 | 2,456 | 523 |
| Net Income Continuous | -41,914 | -64,458 | -42,413 | -18,449 | -17,171 |
| Net Income | $-41,914 | $-64,458 | $-42,413 | $-18,449 | $-17,171 |
| EPS Basic Total Ops | -0.37 | -0.57 | -0.38 | -0.17 | -0.15 |
| EPS Basic Continuous Ops | -0.37 | -0.57 | -0.38 | -0.17 | -0.15 |
| EPS Diluted Total Ops | -0.37 | -0.57 | -0.38 | -0.17 | -0.15 |
| EPS Diluted Continuous Ops | -0.37 | -0.57 | -0.38 | -0.17 | -0.15 |
| EBITDA(a) | $-31,881 | $-54,856 | $-33,577 | $-8,506 | $-8,604 |